RUNX1 gene deregulation, either by genetic alterations (point mutation or chromosome abnormalities) or gene expression modification, is involved in many hematological malignancies, notably in ETV6-RUNX1 pre-B acute lymphoblastic leukemia (BCP-ALL) [6–9]. The gene discussed is ETV6; the disease is acute lymphoblastic leukemia.